Naveris is a biotechnology company that provides clinically validated blood tests for the early detection of cancer.
Naveris has raised $17.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
Naveris's investors include Gurnet Point Capital, TechU Ventures, BrightEdge Fund, Sky Ventures Group, R-Cubed Capital Partners.
Naveris is headquartered in Waltham, United States.
Naveris is a biotechnology company that provides clinically validated blood tests for the early detection of cancer.
Naveris is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Naveris — Funding & Investors." VCBacked, July 2, 2024, https://www.vcbacked.co/company/naveris. Accessed August 14, 2026.
VCBacked. (2024). Naveris — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/naveris
{{cite web |title=Naveris — Funding & Investors |url=https://www.vcbacked.co/company/naveris |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated